Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 19,627 $ 86,411
Restricted cash 3,675 5,650
Inventory 19,351 28,776
Prepaid expenses and other current assets 2,288 3,359
Total current assets 44,941 124,196
Restricted cash 1,002 2,802
Property and equipment, net 3,677 11,625
Operating lease right-of-use assets 12,532 9,612
Other long-term assets 2,858 2,507
Total assets 65,010 150,742
Current liabilities:    
Accounts payable 6,800 8,074
Accrued expenses 11,546 16,020
Deferred revenue 6,340 7,154
Operating lease liabilities, current 1,636 3,489
Other current liabilities 742 306
Total current liabilities 27,064 35,043
Debt, noncurrent 7,500 71,662
Operating lease liabilities, noncurrent 12,949 14,404
Derivative liabilities 1,274 11,511
Total liabilities 48,787 132,620
Commitments and contingencies (Note 6)
Redeemable convertible preferred stock, $0.0001 par value – 100,000,000 shares authorized at December 31, 2024 and December 31, 2023; 25,000 and 10,000 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 24,772 10,000
Stockholders’ equity (deficit):    
Common stock - Class A Common Stock, $0.0001 par value – 600,000,000 shares authorized at December 31, 2024 and December 31, 2023; 35,871,574 and 32,183,695 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively; Class B Common Stock, $0.0001 par value – 200,000,000 shares authorized at December 31, 2024 and December 31, 2023; 3,913,149 and 5,724,199 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 4 4
Additional paid-in capital 639,960 629,208
Accumulated deficit (648,513) (621,090)
Total stockholders’ equity (deficit) (8,549) 8,122
Total liabilities, redeemable convertible preferred stock and stockholders’ equity $ 65,010 $ 150,742